Characterization of the theorectical radiation dose enhancement from nanoparticles.
Recently, nanoparticles have been considered as a method of providing radiation dose enhancement in tumors. In order to quantify this affect, a dose enhancement factor (DEF) is defined that represents the ratio of the dose deposited in tumor with nanoparticles, divided by the dose deposited in the tumor without nanoparticles. Materials with atomic numbers (Z) ranging from 25 to 90 are considered in this analysis. In addition, the energy spectrum for a number of external beam x-ray sources and common radionuclides are evaluated. For a nanoparticle concentration of 5 mg/ml, the DEF is < 1.05 for Co-60, Ir-192, Au-198, Cs-137, 6, 18, and 25 MV x-rays for all materials considered. However, relatively large increases in the DEF are observed for 50, 80, 100, and 140 KVp x-rays as well as Pd-103 and I-125. The DEF increases for all sources as Z varies from 25-35. From Z = 40-60, the DEF plateaus or slightly decreases. For higher Z materials (Z>70), the DEF increases and is a maximum for the highest Z materials. High atomic number nanoparticles coupled with low energy external beam x-rays or brachytherapy sources offer the potential of significantly enhancing the delivered dose.
Roeske
John C
JC
Department of Radiation and Cellular Oncology, The University of Chicago, 5758 S. Maryland Avenue, MC 9006, Chicago, IL 60637, USA. jroeske@radonc.uchicago.edu
Nunez
Luis
L
Hoggarth
Mark
M
Labay
Edwardine
E
Weichselbaum
Ralph R
RR
D000818:Animals; D001918:Brachytherapy / Q000379:methods; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D008962:Models, Theoretical; D053758:Nanoparticles / Q000627:therapeutic use*; D009369:Neoplasms / Q000532:radiotherapy*; D011829:Radiation Dosage; D011868:Radioisotopes / Q000008:administration & dosage*; D011879:Radiotherapy Dosage
D011868:Radioisotopes